GB1076174A - Substituted 1-phenyl-2-aminopropanes - Google Patents
Substituted 1-phenyl-2-aminopropanesInfo
- Publication number
- GB1076174A GB1076174A GB26635/64A GB2663564A GB1076174A GB 1076174 A GB1076174 A GB 1076174A GB 26635/64 A GB26635/64 A GB 26635/64A GB 2663564 A GB2663564 A GB 2663564A GB 1076174 A GB1076174 A GB 1076174A
- Authority
- GB
- United Kingdom
- Prior art keywords
- phenyl
- ethyl
- methylethylamine
- phenoxy
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KWTSXDURSIMDCE-UHFFFAOYSA-N 1-phenylpropan-2-amine Chemical class CC(N)CC1=CC=CC=C1 KWTSXDURSIMDCE-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- URCIJDUOBBSMII-UHFFFAOYSA-N dextrofemine Chemical compound C=1C=CC=CC=1CC(C)NC(C)COC1=CC=CC=C1 URCIJDUOBBSMII-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 abstract 1
- SXLHPBDGZHWKSX-UHFFFAOYSA-N 1-(5-amino-2-hydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC(N)=CC=C1O SXLHPBDGZHWKSX-UHFFFAOYSA-N 0.000 abstract 1
- QWAVNXZAQASOML-UHFFFAOYSA-N 1-phenoxypropan-2-one Chemical compound CC(=O)COC1=CC=CC=C1 QWAVNXZAQASOML-UHFFFAOYSA-N 0.000 abstract 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 108010068370 Glutens Proteins 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- XRMUNMNHHCNRSL-UHFFFAOYSA-N benzene;ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O.C1=CC=CC=C1 XRMUNMNHHCNRSL-UHFFFAOYSA-N 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- 229960004415 codeine phosphate Drugs 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 abstract 1
- 235000021312 gluten Nutrition 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960003893 phenacetin Drugs 0.000 abstract 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 abstract 1
- 210000000626 ureter Anatomy 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR939795A FR1417995A (fr) | 1963-06-28 | 1963-06-28 | Dérivés de la diéthylamine et leur préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1076174A true GB1076174A (en) | 1967-07-19 |
Family
ID=8807211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB26635/64A Expired GB1076174A (en) | 1963-06-28 | 1964-06-26 | Substituted 1-phenyl-2-aminopropanes |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3437731A (en:Method) |
| BE (1) | BE649705A (en:Method) |
| BR (1) | BR6460458D0 (en:Method) |
| DE (1) | DE1493620A1 (en:Method) |
| FR (1) | FR1417995A (en:Method) |
| GB (1) | GB1076174A (en:Method) |
| NL (2) | NL6407309A (en:Method) |
| SE (1) | SE327999B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6087M (en:Method) * | 1967-01-10 | 1968-06-04 | ||
| US3959359A (en) * | 1968-01-23 | 1976-05-25 | Laboratoires Laroche Navarron | Phenoxyalkylamines, process for their preparation and therapeutical composition containing same |
| FR2119843B1 (en:Method) * | 1970-12-28 | 1974-03-22 | Laroche Navarro Labo | |
| US4038319A (en) * | 1970-12-28 | 1977-07-26 | Laboratoires Laroche Navarron | Substituted phenoxyalkylamines, process for their preparation and applications thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1165845A (fr) * | 1955-05-28 | 1958-10-29 | Philips Nv | Amines secondaires portant des substituants et leur préparation |
-
0
- NL NL130079D patent/NL130079C/xx active
-
1963
- 1963-06-28 FR FR939795A patent/FR1417995A/fr not_active Expired
-
1964
- 1964-06-24 BE BE649705A patent/BE649705A/xx unknown
- 1964-06-26 DE DE19641493620 patent/DE1493620A1/de active Pending
- 1964-06-26 SE SE07839/64A patent/SE327999B/xx unknown
- 1964-06-26 BR BR160458/64A patent/BR6460458D0/pt unknown
- 1964-06-26 NL NL6407309A patent/NL6407309A/xx unknown
- 1964-06-26 GB GB26635/64A patent/GB1076174A/en not_active Expired
-
1967
- 1967-02-09 US US643749A patent/US3437731A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3437731A (en) | 1969-04-08 |
| DE1493620A1 (de) | 1969-05-22 |
| FR1417995A (fr) | 1965-11-19 |
| NL6407309A (en:Method) | 1964-12-29 |
| BE649705A (en:Method) | 1964-10-16 |
| SE327999B (en:Method) | 1970-09-07 |
| NL130079C (en:Method) | |
| BR6460458D0 (pt) | 1973-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1517480A (en) | Opiate analgesic formulation with a low potential for abuse | |
| NO155239C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, blandede salter av essensielle eller semi-essensielle aminosyrer og nitrogenfri analoger derav. | |
| ES9000032A1 (es) | Procedimiento de obtencion de composiciones antiinflamatorias y analgesicas para animales homotermos. | |
| EP0210574A3 (en) | N-substituted 5-nitro anthranilic acids, process for their preparation, their use and pharmaceutical compositions based on these compounds | |
| GB1076174A (en) | Substituted 1-phenyl-2-aminopropanes | |
| BR8008818A (pt) | Peptidos farmacologicamente ativos e medicamentos contendo os mesmos | |
| GB1096006A (en) | Substituted biurets | |
| ES470296A1 (es) | Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos | |
| JPS5536453A (en) | Novel immunosuppressive agent | |
| GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
| NO161491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aroyl-5-okso-2-pyrrolidinpropansyre-derivater. | |
| CH613938A5 (en) | Process for the preparation of N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylamine, and the compound prepared by the process | |
| GB1062859A (en) | Improvements in or relating to disubstituted isoxazole compounds and non-toxic salts thereof | |
| AT284093B (de) | Verfahren zur Herstellung der neuen N-(α,α,α,α',α',α'-Hexafluor-3,5-xylyl)-anthranilsäure und ihrer Salze | |
| ES265597A1 (es) | Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina | |
| JPS63198653A (ja) | ムコリチック活性をもつＮ−（トランス−ｐ−ビドロキシ−シクロヘキシル）−（２−アミノ−３，５−ジブロモ）ベンジルアミン塩及びその製法 | |
| GB749485A (en) | Therapeutic compositions containing carbomycin | |
| GB682691A (en) | Manufacture of therapeutically active salts of camphor sulphonic acids | |
| GB933141A (en) | Dextromethorphan n-cyclohexylsulphamate | |
| GB962918A (en) | Improvements in or relating to diaralkylamines and salts thereof | |
| GB936902A (en) | Quinazolinone derivatives | |
| GB1158954A (en) | N-(4-Carboxy-Phenyl)-Anthranilic Acid, derivatives thereof and a process for their preparation | |
| GB773743A (en) | Improvements in the production of pharmaceutically active hexamethylene tetramine complexes | |
| GB734155A (en) | Improvements relating to therapeutic preparations containing isonicotinic acid hydrazide, and their use | |
| GB2127014A (en) | A compound with analgesic and anti-inflammatory activity, a process for producing same and related pharmaceutical compositions |